Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on developing a cure for chronic hepatitis B virus (cHBV) infection. The company leverages its expertise in virology to identify and develop novel therapeutics with distinct mechanisms of action that can be combined to provide a functional cure for patients. Their pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729) and an oral PD-L1 inhibitor, AB-101.

Arbutus Biopharma is headquartered in Warminster, PA, in the heart of the flourishing life sciences industry in the Northeast region of the U.S. They are committed to bringing innovative biopharmaceutical therapeutics to the market, actively seeking collaborators and licensing opportunities within antiviral diseases. Arbutus Biopharma's mission is to bring a cure to patients suffering from HBV and they offer competitive compensation, benefits packages, and opportunities for professional development to their employees.

Arbutus Biopharma offers employees flexibility in their work arrangements, with job-specific opportunities for remote and hybrid work. This allows employees to balance their work life with personal commitments.

Arbutus Biopharma offers a comprehensive benefits package designed to support its employees' well-being and work-life balance. These benefits include competitive base salaries, bonuses, and stock options, as well as 25 paid time off days, 12 paid holidays, and a generous health insurance plan. The company also provides dental coverage, ancillary benefits, a wellness program, and opportunities for remote or hybrid work. Additional benefits include a 401(k) with employer match, an employee stock purchase program, paid parental leave, modern offices with lab space, community service opportunities, and professional development programs.

Arbutus Biopharma is a clinical-stage biopharmaceutical company dedicated to leveraging its extensive virology expertise to identify and develop novel therapeutics. Their mission is to bring these innovative treatments to patients suffering from chronic hepatitis B virus (cHBV) and other viral diseases with unmet medical needs. Arbutus believes in a multi-faceted approach to developing cures, harnessing combination therapies to achieve therapeutic goals and improve patient outcomes.

Arbutus Biopharma fosters a culture focused on collaboration, innovation, and purpose. They seek talented individuals who share their entrepreneurial spirit and thrive in a fast-paced environment. The company values its employees and offers competitive compensation and benefits, along with opportunities for professional development. Their commitment to finding a functional cure for HBV drives a sense of purpose and community, while their location in a thriving life sciences hub in the Northeast provides employees with a vibrant work-life balance.

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, emphasizes building a diverse, equitable, and inclusive workforce. They actively seek out exceptionally talented individuals who share their entrepreneurial spirit and thrive in a fast-paced environment, regardless of background. Arbutus recognizes that a diverse team fosters innovation, creativity, and a stronger company culture. They strive to provide a welcoming and supportive environment for all employees, offering competitive compensation, benefits packages, and opportunities for professional development.